Inhibition of human platelet aggregation by diazeniumdiolates: Extent of inhibition correlates with nitric oxide load delivered

被引:9
|
作者
Raulli, R [1 ]
机构
[1] Amer Red Cross, Jerome H Holland Lab, Cell Biol Lab, Rockville, MD 20853 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb03308.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The profile of nitric oxide (NO) release from the diazeniumdiolate class of NO donors was evaluated using inhibition of platelet aggregation as a model. At 37 degrees C, the NO complexes (Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}-diazen-1-ium-1,2-diolate (dimethylhexanediamine complex), sodium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (diethylamine complex), (Z)-1-{N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]amino}diazeb-1-ium-1,2-diolate (spermine complex), and (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (diethylene-triamine complex) have half-lives of 1, 2 and 39 min, and 20 h, respectively. All the diazeniumdiolates caused concentration-dependent inhibition of platelet aggregation; IC50 values (values for which the effect was half the maximum) were 26.0+/-24.1, 34.9+/-24.0 and 14.9+/-6.4 nM for dimethylhexanediamine complex, diethylamine complex and spermine complex, respectively, when pre-incubated with platelets for one half-life. Inhibition by all compounds was time-dependent. Pretreatment of platelets with spermine complex for 5 and 39 min resulted in IC50 values of 1.7+/-0.85 mu M and 19.7+/-0.12 nM, whereas IC50 values for sodium nitroprusside were 27.3+/-1.25 nM and 25 nM (average, n = 2), at 5 and 39 min, respectively. Pre-incubation of each diazeniumdiolate at a concentration of 100 nM for 5 min at 37 degrees C, which resulted in the theoretical delivery of NO loads from 96.9% down to 0.3%, resulted in decreasingly efficacious inhibition of platelet aggregation. Linear regression analysis of the theoretical NO load delivered against the actual maximum inhibition (%) showed a strong correlation (r(2) = 0.975). All four diazeniumdiolates caused concentration-and time-dependent inhibition of agonist-stimulated elevation of intra-platelet Ca2+ levels; IC50 values were, respectively, 8.7+/-1.49 nM and 11.5+/-1.36 nM for dimethylhexanediamine complex and diethylamine complex at their half-lives, and 176+/-16.9 nM and > 100 mu M, for spermine complex and diethylenetriamine complex at 2 min pre-incubation time. The respective nucleophiles not complexed with NO did not show anti-aggregatory properties or inhibition of agonist-induced elevation of intraplatelet Ca2+ levels. The inhibitory effects of all diazeniumdiolates tested were attenuated by 10 mu M haemoglobin. These studies indicate that these compounds induce controlled, predictable release of NO at biological pH and temperature.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [1] Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation
    Gudmundsdóttir, IJ
    McRobbie, SJ
    Robinson, SD
    Newby, DE
    Megson, IL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (01) : 382 - 385
  • [2] Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin
    Chakraborty, K
    Khan, GA
    Banerjee, P
    Ray, U
    Sinha, AK
    PLATELETS, 2003, 14 (7-8) : 421 - 427
  • [3] The shear rate dependence of nitric oxide inhibition of platelet aggregation
    Sylman, J. L.
    Lantvit, S. M.
    Reynolds, M.
    Neeves, K. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 492 - 492
  • [4] Inhibition of platelet aggregation by nitric oxide donors improves with rest
    Broadley, AJM
    Schmitt, M
    Frenneaux, MP
    PLATELETS, 2003, 14 (06) : 347 - 349
  • [5] Absence of inhibition of platelet aggregation by inhaled nitric oxide (NO) in healthy volunteers
    Samama, CM
    Mourgeon, E
    Puybasset, L
    Lu, Q
    Umama, GS
    Rao, E
    Diaby, M
    Koune, JDL
    Frappier, J
    Arock, M
    Coriat, P
    Rouby, JJ
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1642 - O1642
  • [6] Transport Limitations of Nitric Oxide Inhibition of Platelet Aggregation under Flow
    Sylman, J. L.
    Lantvit, S. M.
    VeDepo, M. C.
    Reynolds, M. M.
    Neeves, K. B.
    ANNALS OF BIOMEDICAL ENGINEERING, 2013, 41 (10) : 2193 - 2205
  • [7] Transport Limitations of Nitric Oxide Inhibition of Platelet Aggregation under Flow
    J. L. Sylman
    S. M. Lantvit
    M. C. VeDepo
    M. M. Reynolds
    K. B. Neeves
    Annals of Biomedical Engineering, 2013, 41 : 2193 - 2205
  • [8] Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates
    Cheung, PY
    Salas, E
    Etches, PC
    Phillipos, E
    Schulz, R
    Radomski, MW
    LANCET, 1998, 351 (9110): : 1181 - 1182
  • [9] Absence of inhibition of platelet aggregation by inhaled nitric oxide in healthy volunteers
    Samama, CM
    Mourgeon, E
    Qin, L
    Diaby, M
    Koune, JDL
    Frappier, J
    Arock, M
    Coriat, P
    Rouby, JJ
    BRITISH JOURNAL OF ANAESTHESIA, 1996, 76 : A174 - A174
  • [10] Inhibition of platelet activation by nitric oxide
    Jensen, BO
    PLATELETS, 1996, 7 (5-6) : 345 - 346